BIO Asia–Taiwan 2022, the region's biggest biotech conference and
exhibition, successfully concluded at the TaiNEX 2 Exhibition Center in
Held in a hybrid format, around 1,500 people from 30 countries
attended the conference and other onsite events while the in-person
exhibition saw more than 100,000 people in attendance.
BIO Asia–Taiwan's recent success is a testament to the robust growth
of the country's biomedical sector. With its theme "Connecting the Asian
Value Chain," the event provided a platform for the global biotech
community to link into Asian supply chains.
Lin, secretary-general of the Taiwan Bio-Industry Organization (Taiwan
BIO) said: "BIO Asia–Taiwan not only provides the platform for Taiwan to
engage with the global biomedical community to help meet these
requirements, but also allows the world to see Taiwan. We aim to cement
Taiwan's role as an essential player in the international value chain."
More than 100 local and foreign experts spoke at 22 conference
sessions. Co-organisers of the conference were PwC Taiwan, Taiwania
Capital, the Development Center for Biotechnology (DCB), the Industrial
Technology Research Institute (ITRI), the Ministry of Health and
Welfare, Academia Sinica, Taipei Medical University, EirGenix, Formosa
Laboratories, Quanta Computer, the Taiwan Digital Health Industry
Development Association, and the Precision Medicine Industry Association
Fully booked with 1,500 booths from 15 participating countries, the
four-day exhibition showcased 550 bio-industry manufacturers. In the
International Zone, 10 countries were featured; the US, the UK, Canada,
Poland, Switzerland, Australia, Malaysia, the Philippines, Belgium and
Meanwhile, the organising committee stated that it had already begun discussions for BIO Asia–Taiwan 2023.